By Life Sciences Report : Rapid growth in the medical device industry and changes in the regulatory environment have propelled valuations in the medtech sector to the high end of the range. But new technologies create new investment opportunities. In this interview with The Life Sciences Report ,
Cytori Therapeutics ( CYTX -1.2% ) appoints Tiago Girao as VP of Finance and CFO effective September 2, 2014. He joins the firm from NuVasive where he was International Controller. Post your comment!
By Andy Batts : NuVasive 's (NASDAQ: NUVA ) bid to escape a $30 ..... negative catalyst for NuVasive 's stock, but I feel ..... it, especially after NUVA posted excellent second ..... 2010, it was found that NuVasive infringed the NeuroVision
Also included are Health Care names: Agios Pharmaceuticals ( AGIO -1.1% ), NPS Pharma ( NPSP +0.7% ), NuVasive ( NUVA -1.8% ), Synageva ( GEVA -1.6% ); Consumer Staples: Darling Ingredients ( DAR -0.8% ); Materials
percentage of overall cases. That's great news for NuVasive (NASDAQ: NUVA ), as is progress toward the sort of operating margins ..... orthopedics space have been relatively lackluster, but NuVasive was a definite exception this time around. Revenue
NuVasive (NASDAQ: NUVA ) Q2 2014 Earnings Call July 29, 2014 5:30 pm ET Executives Carol A. Cox - Executive Vice President of Strategy and Corporate
NuVasive ( NUVA -0.1% ) Q2 results : Revenue: $190.7M (+15.1%); Gross Profit: $145.8M (+24.6%); Operating Expenses
NuVasive (NASDAQ: NUVA ): Q2 EPS of $0.28 beats by $0.03 . Revenue of $190.67M (+15.1% Y/Y) beats by $13.17M . Shares +4.12% AH. Press Release Post your comment!
GPN , GPRE , HTA , HURN , IGT , INAP , INVN , IPHI , IVR , KIM , LNDC , MAR , MOVE , NATI , NCR , NEM , NEU , NFX , NTRI , NUVA , PEI , PLT , PNRA , QGEN , RBC , RGR , RKT , RNG , RNR , ROG , RPXC , RT , RUBI , SB , SLCA , SM , SQNM , TMH , TRN , TWTR
NuVasive 's fortunes are bound to spinal fusion.